Partnerships and pathways of dissemination: The National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network

Journal of Substance Abuse Treatment

Volumn 38, Issue SUPPL. 1, 2010, Pages

  Martino, Steve ^a   Brigham, Gregory S ^b   Higgins, Christine ^c   Gallon, Steve ^d,e   Freese, Thomas E ^f,g   Albright, Lonnetta M ^h,i   Hulsey, Eric G ^j,k   Krom, Laurie ^l   Storti, Susan A ^m   Perl, Harold ⁿ   Nugent, Cathrine D ^o   Pintello, Denise ⁿ   Condon, Timothy P ⁿ  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Maryhaven   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Northwest Frontier Addiction Technology Transfer Center   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f Pacific Southwest Addiction Technology Transfer Center   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Great Lakes Addiction Technology Transfer Center   (United States)

ⁱ UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^j Education and Training in Addictions   (United States)

^k Northeast Addiction Technology Transfer Center   (United States)

^l ATTC National Office   (United States)

^m Synergy Enterprises Inc   (United States)

ⁿ NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^o SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION   (United States)

more..

Author keywords

Buprenorphine; Dissemination; Evidence based treatment; Motivational incentives; Motivational interviewing; Substance abuse; Technology transfer; Treatment adoption; Treatment implementation

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; METHADONE;

ALCOHOLISM; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; COMMUNITY CARE; COUNSELING; DETOXIFICATION; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; INFORMATION DISSEMINATION; INTERDISCIPLINARY COMMUNICATION; INTERNET; INTERVIEW; MEDICAL EDUCATION; MENTAL HEALTH SERVICE; METHADONE TREATMENT; MOTIVATION; OPIATE ADDICTION; PRIORITY JOURNAL; PSYCHOTHERAPY; SHORT COURSE THERAPY; THERAPY EFFECT;

BUPRENORPHINE; CLINICAL TRIALS AS TOPIC; COMMUNITY HEALTH SERVICES; HUMANS; INFORMATION DISSEMINATION; INTERVIEW, PSYCHOLOGICAL; MOTIVATION; NARCOTIC ANTAGONISTS; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); PUBLIC-PRIVATE SECTOR PARTNERSHIPS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TECHNOLOGY TRANSFER; UNITED STATES;

EID: 77950288339     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2009.12.013     Document Type: Article

References (57)

1. Albright L., Hamilton J.A., Kellogg S., Killeen T., Petry N.M., Rosenfeld J., et al. Promoting awareness of motivational incentives from, [accessed on August 24, 2009]. http://www.attcnetwork.org/explore/priorityareas/science/blendingintiative/index.asp.
2. Amass L., Ling W., Freese T.E., Reiber C., Annon J.J., Cohen A.J., et al. Bringing buprenorphine-naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience. The American Journal on Addictions 2004, 13:S42-S66.
3. Ball S.A., Martino S., Nich C., Frankforter T.L., Van Horn D., Crits-Christoph P., et al. Site matters: Motivational enhancement therapy in community drug abuse clinics. Journal of Consulting and Clinical Psychology 2007, 75:556-567.
4. Brigham G. S., (2008). Buprenorphine workgroup blending products survey. Unpublished survey data from the NIDA Clinical Trials Network Research Utilization Committee.
5. Brigham G.S., Amass L., Winhusen T., Harrer J.M., Pelt A. Using buprenorphine short-term taper to facilitate early treatment engagement. Journal of Substance Abuse Treatment 2007, 32:349-356.
6. Brown B.S., Flynn P.M. The federal role in drug abuse technology transfer: A history and perspective. Journal of Substance Abuse Treatment 2002, 22:245-257.
7. Burke B.L., Arkowitz H., Menchola M. The efficacy motivational interviewing: A meta-analysis of controlled trials. Journal of Consulting and Clinical Psychology 2003, 71:843-861.
8. Carroll K.M., Ball S.A., Nich C., Martino S., Frankforter T.L., Farentinos C., et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence 2006, 81:301-312.
9. Carroll K.M., Martino S., Suarez-Morales L., Ball S.A., Miller W.R., Añez L., et al. Multisite randomized controlled effectiveness trial of motivational enhancement for Spanish-speaking substance users. Journal of Consulting and Clinical Psychology 2009, 77:993-999.
10. Condon T.P., Miner L.L., Balmer C.W., Pintello D. Blending addiction research and practice: Strategies for technology transfer. Journal of Substance Abuse Treatment 2008, 35:156-160.
11. Ducharme L.J., Knudsen H.K., Roman P.M., Johnson J.A. Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network. Journal of Substance Abuse Treatment 2007, 32:321-329.
12. Ducharme L.J., Roman P.M. Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoption. Journal of Substance Abuse Treatment 2009, 37:90-94.
13. Fixsen D.L., Naoom S.F., Blasé K.A., Friedman R.M., Wallace F. Implementation research: A synthesis of the literature 2005, University of South Florida, Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network, Tampa, FL, (FMHI Publication #231).
14. Freese T.E., Amass L., Brigham G.S., Clare G., Dixon G., Finnerty B., et al. Buprenorphine treatment: Training for multidisciplinary addiction professionals from, [accessed on August 24, 2009]. http://www.attcnetwork.org/explore/priorityareas/science/blendingintiative/index.asp.
15. Freese T.E., Brigham G.S., Finnerty B., Gresham-Morrison K., Harrer J.M., McCarty D., et al. Short term opioid withdrawal using buprenorphine from, [accessed on August 24, 2009]. http://www.//www.attcnetwork.org/explore/priorityareas/science/blendingintiative/index.asp.
16. Fudala P.J., Bridge T.P., Herbert S., Williford W.O., Chiang C.N., Jones K., et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine 2003, 349:949-958.
17. Fuller B.E., Rieckmann T., Nunes E.V., Miller M., Arken C., Edmundson E., et al. Organizational readiness for change and opinions toward treatment innovations. Journal of Substance Abuse Treatment 2007, 33:183-192.
18. Guydish J., Tajima B., Manser S.T., Jessup M. Strategies to encourage adoption in multisite clinical trials. Journal of Substance Abuse Treatment 2007, 32:177-188.
19. Hanson G.R., Leshner A.I., Tai B. Putting drug abuse research to use in real-life settings. Journal of Substance Abuse Treatment 2002, 23:69-70.
20. Hettema J., Steele J., Miller W.R. Motivational interviewing. Annual Reviews of Clinical Psychology 2005, 1:91-111.
21. Higgins C., & Hulsey E. G., (2009). Motivational incentives workgroup survey. Unpublished survey data from the NIDA Clinical Trials Network Research Utilization Committee.
22. Higgins S.T., Alessi S.M., Dantona R.L. Voucher-based incentives: A substance abuse treatment innovation. Addictive Behaviors 2002, 27:887-910.
23. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E., Donham R., Badger G.J. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Archives of General Psychiatry 1994, 51:568-576.
24. Higgins S.T., Silverman K., Heil S.H. Contingency management in substance abuse treatment 2008, Guilford Press, New York.
25. Horvatich P. Enhancing the EBP repertoire of substance abuse counselors: A commentary on Kerwin, Walker-Smith, and Kirby. Journal of Substance Abuse Treatment 2006, 30:171-172.
26. Johnson R.E., Strain E.C., Amass L. Buprenorphine: How to use it right. Drug and Alcohol Dependence 2003, 70:S59-S77.
27. Kirby K.C., Benishek L.A., Dugosh K.L., Kerwin M.L. Substance abuse treatment providers' beliefs about objections regarding contingency management: Implications for dissemination. Drug and Alcohol Dependence 2006, 85:19-27.
28. Knudsen H.K., Abraham A.J., Johnson J.A., Roman P.M. Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 2009, 37:307-312.
29. Lewis J.W. Buprenorphine. Drug and alcohol dependence. 14 1985, 363-372.
30. Ling W., Amass L., Shoptaw S., Annon J.J., Hillhouse M., Babcock D., et al. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction 2005, 100:1090-1100. & the Buprenorphine Study Protocol Group.
31. Ling W., Hillhouse M., Domier C., Doraimani G., Hunter J., Thomas C., et al. Buprenorphine tapering schedule and illicit opioid use. Addiction 2009, 104:256-265.
32. Ling W., Wesson D. Clinical efficacy of buprenorphine: Comparisons to methadone and placebo. Drug and Alcohol Dependence 2003, 70:S49-57.
33. Lundahl B. W., Tollefson D., Gambles C., Brownell C., & Burke B. L., (in press). A meta-analysis of motivational interviewing: Twenty five years of empirical studies. Research on Social Work Practice.
34. Martino S., (2009a) MIA: STEP workgroup trainer survey. Unpublished survey data from the NIDA Clinical Trials Network Research Utilization Committee.
35. Martino S. Effectiveness of motivational interviewing supervision in community programs 2009, (NIDA R01DA023230).
36. Martino S., Ball S.A., Gallon S.L., Hall D., Garcia M., Ceperich S., et al. Motivational interviewing assessment: Supervisory tools for enhancing proficiency 2006, Northwest Frontier Addiction Technology Transfer Center, Oregon Health and Science University, Salem, OR, from, [accessed on August 24, 2009]. http://www.attcnetwork.org/explore/priorityareas/science/blendingintiative/index.asp.
37. Martino S., Ball S.A., Nich C., Frankforter T.L., Carroll K.M. Community program therapist adherence and competence in motivational enhancement therapy. Drug and Alcohol Dependence 2008, 96:37-48.
38. Martino S., Ball S.A., Nich C., Frankforter T.L., Carroll K.M. Informal discussions in substance abuse treatment sessions. Journal of Substance Abuse Treatment 2009, 36:355-365.
39. Martino S., Ball S.A., Nich C., Frankforter T.L., Carroll K.M. Correspondence of motivational enhancement treatment integrity ratings among therapists, supervisors, and observers. Psychotherapy Research 2009, 19:181-193.
40. Miller W.R., Rollnick S. Motivational interviewing: Preparing people for change 2002, Guilford Press, New York. 2nd ed.
41. Miller W.R., Yahne C.E., Moyers T.E., Martinez J., Pirritano M. A randomized trial of methods to help clinicians learn motivational interviewing. Journal of Consulting and Clinical Psychology 2004, 72:1050-1062.
42. Miller W.R., Zweben A., DiClemente C.C., Rychtarik R.G. Motivational enhancement therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. (Vol 2, Project MATCH Monograph Series) 1992, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
43. Moyers T.B., Martin T., Manuel J.K., Hendrickson S.M.L., Miller W.R. Assessing competence in the use of motivational interviewing. Journal of Substance Abuse Treatment 2005, 28:19-26.
44. Onken L.S., Blaine J.D., Battjes R. Behavioral therapy research: A conceptualization of a process. Innovative approaches for difficult to treat populations 1997, 477-485. Psychiatric Press, Washington, DC. S.W. Henggeler, R. Amentos (Eds.).
45. Petry N.M., Kolodner K.B., Li R., Peirce J.M., Roll J.M., Stitzer M.L., et al. Prize-based contingency management does not increase gambling. Drug and Alcohol Dependence 2006, 83:269-273.
46. Petry N.M., Martin B. Lower-cost contingency management for treating cocaine-abusing methadone patients. Journal of Consulting and Clinical Psychology 2002, 70:398-405.
47. Petry N.M., Martin B., Cooney J.L., Kranzler H.R. Give them prizes and they will come: Contingency management treatment of alcohol dependence. Journal of Consulting and Clinical Psychology 2000, 68:250-257.
48. Petry N.M., Peirce J.M., Stitzer M.L., Blaine J., Roll J.M., Cohen A., et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A National Drug Abuse Treatment Clinical Trials Network Study. Archives of General Psychiatry 2005, 62:1148-1156.
49. Pierce J.M., Petry N.M., Stitzer M.L., Blaine J., Kellogg S., Satterfield F., et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Institute on Drug Abuse Treatment Clinical Trials Network study. Archives of General Psychiatry 2006, 63:1148-1156.
50. Rounsaville B.J., Carroll K.M., Onken L.S. A stage model of behavioral therapies research: Getting started and moving on from Stage I. Clinical Psychology: Science and Practice 2001, 8:133-142.
51. Santa Ana E.J., Carroll K.M., Añez L., Paris M., Ball S.A., Nich C., et al. Evaluating motivational enhancement therapy adherence and competence among Spanish-speaking therapists. Drug and Alcohol Dependence 2009, 103:44-51.
52. Simpson D.D. A conceptual framework for transferring research to practice. Journal of Substance Abuse Treatment 2002, 22:171-182.
53. Simpson D.D., Flynn P.M. Moving innovations into treatment: A stage-based approach to program change. Journal of Substance Abuse Treatment 2007, 33:111-120.
54. Squires D.D., Gumbley S.J., Storti S.A. Training substance abuse treatment organizations to adopt evidence-based practices: The Addiction Technology Transfer Center of New England Science to Service Laboratory. Journal of Substance Abuse Treatment 2008, 34:293-301.
55. Stitzer M.L., Iguchi M.Y., Felch L.J. Contingent take-home incentives: Effects on drug use of methadone maintenance patients. Journal of Consulting and Clinical Psychology 1992, 60:927-934.
56. Stitzer M.L., Kellogg S. Large-scale dissemination efforts in drug abuse treatment clinics. Contingency management in substance abuse treatment 2008, 241-260. Guilford Press, New York. S.T. Higgins, K. Silverman, S.H. Heil (Eds.).
57. Woody G.E., Poole S.A., Subramaniam G., Dugosh K., Bogenschutz M., Abbott P., et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth. Journal of the American Medical Association 2008, 300:2003-2013.